特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の糖尿病モニタリング装置市場:動向と予測

Diabetes Monitoring Devices Market, by Product Type, Indication, Approach, End User, and Region - Global Trends, and Forecast to 2025

発行 Coherent Market Insights 商品コード 629623
出版日 ページ情報 英文 205 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
世界の糖尿病モニタリング装置市場:動向と予測 Diabetes Monitoring Devices Market, by Product Type, Indication, Approach, End User, and Region - Global Trends, and Forecast to 2025
出版日: 2018年02月24日 ページ情報: 英文 205 Pages
概要

当レポートでは、世界の糖尿病モニタリング装置市場について調査し、市場の概要と製品タイプ別、技術別、適応別、アプローチ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 調査目的と仮定

第2章 市場概要

第3章 市場動向、法規制、動向分析

  • 市場動向
    • 促進因子
    • 阻害因子
    • 市場の機会
  • 主なハイライト
  • 償還シナリオ
  • 技術進歩
  • 近年のFDA認可
  • 糖尿病モニタリング装置市場に対するFDAガイドライン
  • 疫学

第4章 製品別

  • イントロダクション
  • 血糖値自己モニタリング装置
  • 連続的血糖モニタリング装置

第5章 適応別

  • イントロダクション
  • 1型糖尿病
  • 2型糖尿病
  • 消化器疾患

第6章 アプローチ別

  • イントロダクション
  • 侵襲性
  • 非侵襲性

第7章 エンドユーザー別

  • イントロダクション
  • 病院
  • クリニック
  • 外来外科センター
  • ホームケア施設
  • その他

第8章 地域別

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋地域
  • 中東
  • アフリカ

第9章 競合環境

  • ヒートマップ分析
  • 市場シェア分析
  • 企業プロファイル

第10章 セクション

目次

Diabetes refers to a group of metabolic diseases in which a person suffers from high or low levels of blood sugar levels for a prolonged period. Most common symptoms of diabetes includes increased thirst, increased urination, and increased hunger. Diabetes is one the prime diseases that carries risk of chronic cardiovascular diseases and can also lead to life-threatening events such as cardiac arrests or heart failure. Thus, it is a preliminary requirement for diabetic patient to monitor blood glucose levels at frequent time intervals, which can be achieved by diabetes monitoring devices.

Market Dynamics

The major factors contributing the growth of global diabetes monitoring devices market are increasing number of patients suffering from diabetes across the world. According to the World Health Organization (WHO) 2014, diabetes is one of the diseases that has dire consequences on health, which affected around 422 million people across the world in 2014. Moreover, it has resulted in approximately 1.6 million deaths in 2015, which increases the demand for management solutions. Moreover, obesity is one of the other prominent factor that leads to the cause of diabetes in most of the obese patients. According to The National Institute of Diabetes and Digestive and Kidney Diseases, Statistics on Diabetes 2015, over 90% of patients suffering from diabetes were reported to be obese. However, the high cost of these devices coupled with the calibration errors associated with these devices are hindering the market growth. The research and development in the area of continuous glucose monitors are expected to provide growth opportunities for new and established market players to capitalize upon and witness growth in terms of sales, as these devices are in high demand due to the hassle free diabetes monitoring records that they provide in real time at a go.

Key features of the study:

This report provides in-depth analysis of diabetes monitoring devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2017 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global diabetes monitoring devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans

Key companies covered as a part of this study Bayer Healthcare AG, Medtronic, Dexcom, Sanofi S.A., Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, MediWise, Arkay, Inc., Cnoga Medical, and Bigfoot Biomedical.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global diabetes monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the diabetes monitoring devices market

Detailed Segmentation:

  • Global Diabetes Monitoring Devices Market, By Product Type:
  • Self-Monitoring Glucose Devices
  • Continuous Glucose Monitoring Devices
  • Global Diabetes Monitoring Devices Market, By Indication:
  • Type-I Diabetes
  • Type-II Diabetes
  • Gestational Diabetes
  • Global Diabetes Monitoring Devices Market, By Approach:
  • Invasive
  • Non-Invasive
  • Global Diabetes Monitoring Devices Market, By End User:
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Centers
  • Others
  • Global Diabetes Monitoring Devices Market, By Geography:
  • North America
  • By Product Type:
  • Self-Monitoring Glucose Devices
  • Continuous Glucose Monitoring Devices
  • By Indication:
  • Type-I Diabetes
  • Type-II Diabetes
  • Gestational Diabetes
  • By Approach:
  • Invasive
  • Non-Invasive
  • By End User:
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Centers
  • Others
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Product Type:
  • Self-Monitoring Glucose Devices
  • Continuous Glucose Monitoring Devices
  • By Indication:
  • Type-I Diabetes
  • Type-II Diabetes
  • Gestational Diabetes
  • By Approach:
  • Invasive
  • Non-Invasive
  • By End User:
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Centers
  • Others
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Product Type:
  • Self-Monitoring Glucose Devices
  • Continuous Glucose Monitoring Devices
  • By Indication:
  • Type-I Diabetes
  • Type-II Diabetes
  • Gestational Diabetes
  • By Approach:
  • Invasive
  • Non-Invasive
  • By End User:
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Centers
  • Others
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type:
  • Self-Monitoring Glucose Devices
  • Continuous Glucose Monitoring Devices
  • By Indication:
  • Type-I Diabetes
  • Type-II Diabetes
  • Gestational Diabetes
  • By Approach:
  • Invasive
  • Non-Invasive
  • By End User:
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Centers
  • Others
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Product Type:
  • Self-Monitoring Glucose Devices
  • Continuous Glucose Monitoring Devices
  • By Indication:
  • Type-I Diabetes
  • Type-II Diabetes
  • Gestational Diabetes
  • By Approach:
  • Invasive
  • Non-Invasive
  • By End User:
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Centers
  • Others
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type:
  • Self-Monitoring Glucose Devices
  • Continuous Glucose Monitoring Devices
  • By Indication:
  • Type-I Diabetes
  • Type-II Diabetes
  • Gestational Diabetes
  • By Approach:
  • Invasive
  • Non-Invasive
  • By End User:
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Centers
  • Others
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Bayer AG *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Roche Diagnostics
  • Johnson & Johnson
  • Medtronic plc
  • Dexcom, Inc.
  • Abbott Laboratories Ltd.
  • MediWise
  • Arkay, Inc.
  • Cnoga Medical
  • Bigfoot Biomedical
  • Sanofi S.A.
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Indication
    • Market Snippet, By Approach
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Key Highlights
  • Reimbursement Scenario
  • Technological Advancements
  • Recent FDA Approvals
  • FDA Guidelines for Diabetes Monitoring Devices Market
  • Epidemiology

4. Global Diabetes Monitoring Devices Market, By Product Type, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016 - 2025
    • Segment Trends
  • Self-Monitoring Blood Glucose Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
  • Continuous Glucose Monitoring Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)

5. Global Diabetes Monitoring Devices Market, By Indication, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016 - 2025
    • Segment Trends
  • Type-I Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
  • Type-II Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
  • Gestational Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)

6. Global Diabetes Monitoring Devices Market, By Approach, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016 - 2025
    • Segment Trends
  • Invasive
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
  • Non-Invasive
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)

7. Global Diabetes Monitoring Devices Market, By End User, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016 - 2025
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015 - 2025, (US$ Million)

8. Global Diabetes Monitoring Devices Market, By Region, 2017 - 2025, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, For Region, 2016 - 2025
  • North America
    • Market Size and Forecast, By Product Type, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Indication, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Approach, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By End User, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Indication, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Approach, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By End User, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Indication, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Approach, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By End User, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Indication, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Approach, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By End User, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Product Type, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Indication, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Approach, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By End User, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Indication, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Approach, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By End User, 2015 - 2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Bayer AG*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
    • Roche Diagnostics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
    • Johnson & Johnson
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
    • Medtronic plc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
    • Dexcom, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
    • MediWise
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
    • Arkay, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
    • Cnoga Medical
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
    • Bigfoot Biomedical
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
    • Sanofi
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact